Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

The investigational therapy from Innovent Biologics, Inc. displayed significantly greater urate-lowering efficacy versus febuxostat, along with a favorable safety profile.

Tigulixostat Proves Superiority to Febuxostat in Patients with Gout and Hyperuricemia

Despite high cardiovascular risk with the 2 comorbidities, no beneficial effect was seen with colchicine.

Colchicine Did Not Reduce MACE Risk in People With Gout and Type 2 Diabetes

A recent study reveals gout patients face higher chronic opioid prescription rates.

People With Gout at Risk for Chronic Opioid Use

Allopurinol and febuxostat, recently associated with significant risk of macrovascular disorders, have no increased risk of microvascular conditions.

Gout Therapies Allopurinol, Febuxostat Do Not Increase Retinal Microvascular Disorder Risk

Using an established full and simplified definition, investigators found a substantial percentage of the MIRROR population achieved gout remission.

Pegloticase Yields Complete Gout Remission in Post Hoc Analysis

New research reveals challenges in maintaining urate-lowering therapy for gout, highlighting disparities in adherence among diverse patient populations.

Study Finds Limited Durability After Treat-to-Target ULT Interventions for Gout

Machine learning uncovers gut microbiome biomarkers linked to purine metabolism, enhancing diagnostic strategies for gout and hyperuricemia.

Machine Learning Identifies Role of Impaired Purine Metabolism in Gout Pathogenesis

A new study reveals that gout significantly affects hand function, with manual dexterity impairments nearly as severe as those seen in rheumatoid arthritis.


Gout Impairs Hand Dexterity, Grip Endurance Comparable to RA, Study Finds

The AGILE and FORWARD studies found comparable efficacy and safety with shorter doses and higher dose, monthly doses, compared to the pivotal MIRROR trial.

Phase 4 Studies Support Alternative Pegloticase Dosing Regimens for Uncontrolled Gout, with Orrin Troum, MD

Explore groundbreaking FDA approvals and clinical trial advancements in rheumatology, offering new hope for patients with rare autoimmune diseases and chronic conditions.

H1 2025 Recap: 7 Rheumatology Updates to Know

On the HCPLive gout page, resources on the topics of medical news and expert insight into gouty arthritis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on gout, and more.